Min Irwin is the founder of Reistone Biopharma. Reistone Biopharma has raised $100M in total funding. Latest round: Series A. Based in Shanghai, China.
Min Wang Irwin is the Co-Founder and CEO of Reistone Biopharma, a clinical-stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases. Headquartered in Shanghai, she leads global clinical programs, including Phase II trials for ulcerative colitis and Phase III trials for atopic dermatitis. Irwin has overseen the company's progression to Series A funding and multiple FDA IND approvals.
Full founder directory · Investor directory · Company funding database · Fundraising library